|
Status |
Public on Mar 06, 2020 |
Title |
EOC5: Female high grade serous ovarian cancer, primary tumor |
Sample type |
genomic |
|
|
Source name |
Female high grade serous ovarian cancer, primary tumor
|
Organism |
Homo sapiens |
Characteristics |
gender: female grade: high grade serous ovarian cancer, primary tumor grade: 3 histotype: serous patient age: 77
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Genomic DNA was isolated using the Puregene Tissue Kit (Qiagen)
|
Label |
biotin
|
Label protocol |
Probe labeling was performed according to manufactures recomendation for Affymetrix Cytoscan HD microarrays
|
|
|
Hybridization protocol |
Hybridizations were performed according to manufactures recomendation for Affymetrix Cytoscan HD microarrays
|
Scan protocol |
Microarray scans were performed according to manufactures recomendation for Affymetrix Cytoscan HD microarrays
|
Data processing |
The total number and size (segments) of CNA per sample were determined using the Affymetrix Chromosome Analysis Suite (ChAS) Software. A CNA index was calculated for each sample based on the percent of the genome that resulted in either a copy number loss or gain. *Segments.txt: Total number and size of copy number gain and loss segments across genome
|
|
|
Submission date |
Mar 06, 2020 |
Last update date |
Mar 08, 2020 |
Contact name |
Adam R Karpf |
E-mail(s) |
adam.karpf@unmc.edu
|
Phone |
402-559-6115
|
Organization name |
UNMC
|
Street address |
S 42nd &, Emile St
|
City |
Omaha |
State/province |
NE |
ZIP/Postal code |
68198 |
Country |
USA |
|
|
Platform ID |
GPL16131 |
Series (2) |
GSE146554 |
Global DNA hypomethylation in ovarian cancer (CNV_data) |
GSE146556 |
Global DNA hypomethylation in ovarian cancer |
|